Well at least its getting interesting. East Hill are looking for...

Well at least its getting interesting. East Hill are looking for a spill of Directors and are opposed to the merger. It appears there is a group, so they may have some chance of success.

The 2 million dollar break fee "negotiated" by the Aviragen management is outrageous. Its essentially extortion against shareholders who oppose the deal.

I notice that Aviragen received an unconditional cash offer of 81 cents during the last few months and rejected it. Yet the valuation of Aviragen into the merger reflected the current share price, not 81 cents. Bizzare